NCT04568824

Brief Summary

The current project will carry out a large-scale, randomized controlled trial (RCT) to examine the effectiveness of a home-administered technology-based treatment for reading disability (GraphoLearn) in a diagnostically diverse children with reading disability (ages 6.0-10.00). To accomplish this rapidly and with minimal cost, the experimenters will leverage the Healthy Brain Network \[HBN\], an ongoing study of mental health and learning disorders in children ages 5.0-21.0 whose family have one or more concerns about behavior and/or learning (target n = 10,000; current enrollment = 3000+). The HBN includes comprehensive psychiatric, cognitive, electroencephalogram \[EEG\] and multimodal magnetic resonance imaging \[MRI\] characterizations for all participants, providing the present work rich data to build from. The present work will recruit 450 children (ages 6.0-10.0) with reading difficulty from the HBN. In order to evaluate GraphoLearn effectiveness the experimenters will compare reading (and related language skills) before and after a 12-week GraphoLearn reading intervention relative to an active (math) control. The experimenters also assess the stability of the reading gains by including a 12 week retention period ( with pre and post retention assessment). The experimenters hypothesize that they will observe significant gains in reading (and related language) skills relative to the math control conditions, but that these gains will be variable and predicted by participant and environment level factors (predictive models are explored under Aim 2). This evaluation will involve a 3 to 4 visit between groups longitudinal study with cross over elements to evaluate GraphoLearn in struggling readers ages 6-10 using and pre-post behavioral and EEG assessment.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
450

participants targeted

Target at P75+ for not_applicable

Timeline
3mo left

Started Nov 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress96%
Nov 2020Aug 2026

First Submitted

Initial submission to the registry

September 23, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 29, 2020

Completed
2 months until next milestone

Study Start

First participant enrolled

November 15, 2020

Completed
4.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 29, 2025

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2026

Expected
Last Updated

September 2, 2025

Status Verified

August 1, 2025

Enrollment Period

4.8 years

First QC Date

September 23, 2020

Last Update Submit

August 29, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Test of Word Reading Efficiency (TOWRE II), total word reading efficiency (TWRE) measure

    The TWRE is a composite of phonemic decoding efficiency (PDE) and sight word efficiency (SWE) -- subtests from the TOWRE II -- these are timed measures of word and nonword reading. The range of scores for the TWRE is 53- 147. Higher scores indicate better performance. Greater change equals better outcome/response.

    Assessment is given before and after the intervention, ~12 weeks apart for the primary outcome; the assessment will also be re-administered after a 12 week retention period

Secondary Outcomes (3)

  • Woodcock Johnson Tests of Achievement (WJ-IV), Letter Word identification (ID) and Word Attack subtests.

    Assessment is given before and after the intervention, ~12 weeks apart; the assessment will also be re-administered after a 12 week retention period.

  • Phonological Awareness (PA), Phonological Memory, (PM) and Rapid Naming (RN), which are composite scores and will be assessed with the Comprehensive Test of Phonological Processing (CTOPP-II)

    Assessment is given before and after the intervention, ~12 weeks apart; the assessment will also be re-administered after a 12 week retention period.

  • EEG measures of phonological discrimination and letter sound processing/integration

    Assessment is given before and after the intervention, ~12 weeks apart.

Study Arms (2)

GraphoLearn reading intervention

EXPERIMENTAL

GraphoLearn is a research-based treatment, delivered as an engaging computer game. Players match auditory targets (e.g., phonemes, rimes) to visual targets (single letters, letter sequences, words). The complexity of the items within each level is ordered such that at each level, the most frequent and regular mappings are introduced first based on measures such as orthographic/phonological neighborhood size and morphological family size. GraphoLearn allows the children to practice and reinforce lessons at their own individual trial pace and provides a record of performance progress that can be used to guide analyses.

Other: GraphoLearn reading intervention

Vektor math control

ACTIVE COMPARATOR

We selected an active control to maximize the specificity of the treatment outcomes; to this end, math games are among the most commonly used. Game sessions support learning numerical mathematical skills and cognition related to mathematical skills. In addition to math, this game contains training tasks for visuospatial working memory, spatial visualization and visuospatial reasoning. The overall theme of the game and feedback style are similar to those in GraphoLearn.

Other: Vektor math control intervention

Interventions

This is an Edtech reading intervention

GraphoLearn reading intervention

This is an Edtech math/cognition intervention

Vektor math control

Eligibility Criteria

Age6 Years - 10 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Must be 6.0 to 10.0 years old
  • Must be currently enrolled in Healthy Brain Network (HBN)
  • Must have a standard score \<85, on the Test of Word Reading Efficiency (TOWRE), Total Word Reading Efficiency (TWRE) composite
  • Must have full Scale IQ (FSIQ) on the Wechsler Intelligence Scale for Children (WISC V) \> 75
  • Must be a native speaker of English

You may not qualify if:

  • Vision or hearing impairment, per the Snellen Test and audiometer measurement
  • Moderate to severe autism (levels 2-3)
  • Major depressive disorder
  • Suicidal or homicidal ideation
  • Psychotic disorder
  • Manic episode
  • Any neurologic impairment that limits the ability to use a keyboard or mouse, or to touch a screen

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Child Mind Institute

New York, New York, 10022, United States

Location

MeSH Terms

Conditions

Dyslexia

Condition Hierarchy (Ancestors)

Language DisordersCommunication DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSpecific Learning DisorderLearning DisabilitiesSigns and SymptomsPathological Conditions, Signs and SymptomsNeurodevelopmental DisordersMental Disorders

Study Officials

  • Nicole Landi, PhD

    University of Connecticut

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
The only masking is done at the level of data analysis, as it is readily evident to participants and those monitoring which group the participants are in.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This is a parallel intervention design with crossover elements (control group is offered the intervention after completion of the control intervention). We will evaluate a reading intervention of interest in comparison to a math control.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

September 23, 2020

First Posted

September 29, 2020

Study Start

November 15, 2020

Primary Completion

August 29, 2025

Study Completion (Estimated)

August 1, 2026

Last Updated

September 2, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will share

Consistent with the policies established by one of the principal investigators (PIs), PI Milham and colleagues on the International Neuroimaging Data-sharing Initiative (INDI), all data will be anonymized prior to being placed in the data repository. All phenotypic data collected during the proposed work, including daily GraphoLearn longitudinal training data, will be shared following completion of data collection, which is anticipated to occur prior to the end of year 4. EEG data obtained through the proposed work will be shared through INDI as well.

Shared Documents
ANALYTIC CODE
Time Frame
after study completion
Access Criteria
undecided

Locations